Suppr超能文献

新型、文化敏感型、共病医疗预约模式在西班牙裔儿科 1 型糖尿病患者中的应用。

Novel, culturally sensitive, shared medical appointment model for Hispanic pediatric type 1 diabetes patients.

机构信息

Barbara Davis Center, University of Colorado, Aurora, Colorado.

出版信息

Pediatr Diabetes. 2019 Jun;20(4):468-473. doi: 10.1111/pedi.12852. Epub 2019 Apr 15.

Abstract

BACKGROUND/OBJECTIVE: Latino patients with type 1 diabetes (T1D) face cultural and language barriers leading to poor outcomes. Shared medical appointments (SMAs) are recognized as effective models of care. Our aim is to develop a culturally sensitive, cost effective SMA program for Latino T1D.

SUBJECTS

Spanish speaking Latinos 1 to 20 years with T1D (n = 88) and their families.

METHODS

Routine care alternating with SMAs that included group education was provided. Teens, ages >11 received the SMA separate from parents. Younger children were seen together. Hemoglobin A1c (HbA1c), behavioral questionnaires, and use of diabetes technology were measured at baseline and every 3 to 6 months.

RESULTS

57.7% of children and 77.27% of teens completed the 2 years of the Program. There was a significant association between age and change in HbA1c from baseline to year 1 (P = .001) and baseline to year 2 (P = <.0001). For participants <12 years, there was a significant improvement in HbA1c from baseline to year 1 (P = .0146) and from year 1 to year 2 (P = .0069). Participants ≥12 years, had an increase in HbA1c from year 1 to year 2 (P = .0082). Technology use increased significantly from baseline to year 2 for participants <12 years of age (19%-60%, P = .0455) and for participants who were ≥12 years of age (10%-23%, P = .0027). Participants reported a 98% satisfaction rate.

CONCLUSIONS

The culturally sensitive SMA proved to be an appreciated, feasible, and effective alternative to care for Latinos with T1D.

摘要

背景/目的:患有 1 型糖尿病(T1D)的拉丁裔患者面临着文化和语言障碍,导致治疗效果不佳。共同就诊(SMA)被认为是一种有效的治疗模式。我们的目标是为拉丁裔 T1D 患者开发一种文化敏感且具有成本效益的 SMA 项目。

对象

西班牙语裔拉丁裔 1 至 20 岁的 T1D 患者(n=88)及其家属。

方法

提供常规护理和 SMA 交替服务,其中包括小组教育。11 岁以上的青少年将在与父母分开的 SMA 中接受治疗。年幼的孩子则一起接受治疗。在基线和每 3 至 6 个月测量糖化血红蛋白(HbA1c)、行为问卷和糖尿病技术的使用情况。

结果

57.7%的儿童和 77.27%的青少年完成了该项目的 2 年治疗。从基线到第 1 年(P=0.001)和从基线到第 2 年(P<.0001),HbA1c 的变化与年龄之间存在显著关联。对于<12 岁的参与者,HbA1c 从基线到第 1 年(P=0.0146)和从第 1 年到第 2 年(P=0.0069)都有显著改善。≥12 岁的参与者从第 1 年到第 2 年 HbA1c 有所增加(P=0.0082)。对于<12 岁的参与者,从基线到第 2 年,技术使用率显著增加(19%-60%,P=0.0455);对于≥12 岁的参与者,技术使用率也显著增加(10%-23%,P=0.0027)。参与者的满意度为 98%。

结论

这种文化敏感的 SMA 被证明是一种为拉丁裔 T1D 患者提供的可接受、可行且有效的治疗替代方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验